New York, NY (November 21, 2002) -- More than 60-million Americans suffer from allergies, and as many as 40 million suffer from airborne allergies. Yet, despite their prevalence and the ever-increasing numbers of allergy sufferers, there is still widespread misunderstanding about allergies. Now, a new book by a leading Weill Cornell allergist clears the air about allergies and distinguishes the fact from the fiction.The book, entitled "What's In the Air? The Complete Guide to Seasonal and Year-Round Airborne Allergies," is authored by Dr. Gillian Shepherd, Clinical Associate Professor of Medicine at Weill Cornell Medical College, and Marian Betancourt. It is available in paperback and published by Pocket Books.
Engineer and physicist Harold Craighead of Cornell University has been awarded $750,000 by a New York state research agency to develop a chip-based analytical system for rapid analysis of chemical and biological compounds. Craighead, the C.W. Lake Jr. Professor of Engineering and professor of applied and engineering physics at Cornell, received the award through the New York State OfÞce of Science, Technology and Academic Research's (NYSTAR) Faculty Development Program. The funds are designed to assist universities in the recruitment and retention of leading research faculty in science and technology Þelds with strong commercial potential. (November 20, 2002)
The Hon. Art Eggleton, a member of the Parliament of Canada, will visit Cornell University Friday, Nov. 22, to give a talk on "Canada-U.S. Relations in the Post-9/11 Era." The lecture, which is free and open to the public, will be in the Hollis E. Cornell Auditorium of Goldwin Smith Hall from 2:30 to 4 p.m. (November 20, 2002)
A four-year, $650,000 Research Scholar Grant from the American Cancer Society (ACS) will help Cornell University biologist W. Lee Kraus, assistant professor of molecular biology and genetics, and his laboratory group learn more about how the hormone estrogen regulates the growth of cells in the human body -- including cells that develop into breast cancers. Kraus credits a graduate student in his Cornell laboratory, Mi Young Kim, with the discovery of two enzymes that apparently act on the hormone-binding proteins that bind estrogens inside cells. The Cornell researchers now hope to learn how these estrogen receptor-modifying enzymes, called an acetylase and a deacetylase, alternately add or remove acetyl groups at the receptor. They also hope to learn what effect these modifications have on the activity of the receptors in normal and cancerous human mammary cells. (November 19, 2002)
N.Y. -- If you plan to go over the river or through the woods this Thanksgiving, consider snow tires. The holiday falls on Nov. 28 this year, and for the northern parts of the northeast United States, that means a good chance of snow. Cornell University's Northeast Regional Climate Center predicts a 67 percent likelihood of an inch of snow on the ground in Caribou, Maine, on Thanksgiving morning, and a 34 percent possibility in Burlington, Vt. Not far behind is Concord, N.H., with a 29 percent chance. Keith Eggleston, senior climatologist at the center, based his predictions on a 30-year average of Northeast snowfall, from 1971 to 2000. (November 19, 2002)
New York, NY (November 18, 2002) -- A new study by doctors at the NewYork-Presbyterian Hospital Weill Cornell Medical Center shows that the Center's unique diagnostic technology of magnetic resonance angiography (MRA) is the equal of the traditional technique of x-ray angiography in helping physicians plan treatment for patients with peripheral vascular disease (PVD). MRA, which is much less invasive than x-ray angiography, can now be considered as the appropriate and standard diagnostic technique not only for mild forms of PVD but for severe forms as well.The new study, recently published in the journal "Radiology," is the first to show that MRA is useful in guiding the planning of treatment for severe as well as mild PVD. PVD, which afflicts many elderly people, involves a narrowing or obstruction of arteries in the lower body, particularly the legs or feet. In its mildest form, it can lead to pain in walking and is called claudication. In its more severe form, it can lead to pain in the feet at rest as well as foot gangrene and ulcerations.
During the Thanksgiving holiday season from Nov. 18 to Dec. 1, Cornell University Police will join police agencies throughout New York state in a wave of "zero tolerance" enforcement of the seat belt laws. "Many students will be driving home for the Thanksgiving holiday, and we want to help ensure a safe trip home and back for them," said Sgt. Charles Howard, coordinator of traffic enforcement activities for Cornell Police. (November 18, 2002)
Environmental sculptor Andy Goldsworthy will present a public lecture "Rivers and Tides: Andy Goldsworthy Working with Time," on Dec. 4 , at 7:30 p.m. in the David Call Alumni Auditorium of Kennedy Hall on the Cornell campus.
New York, NY -- NewYork Weill Cornell Medical Center of NewYork-Presbyterian Hospital is currently seeking patients for a nationwide, multicenter clinical research trial to explore the benefits of a unique vaccine to treat low-grade follicular non-Hodgkin's lymphoma (NHL). This randomized Phase 3 study will test a personalized immunotherapy vaccine created from a patient's own tumor cells to potentially combat the cancer and interfere with disease progression. NewYork Weill Cornell is the only site in New York State participating in this trial. "This study is for patients with previously untreated, advanced stage low-grade non-Hodgkin's lymphoma who want to use their own immune system as a first line of defense to fight the disease," said John P. Leonard, M.D., Assistant Professor of Medicine, Medical Director, Oncology Services, Weill Cornell Medical College of Cornell University, and investigator on the trial. "Low-grade NHL is a cancer with no readily available cure, and conventional treatments such as chemotherapy and radiation have been shown to lose efficacy and cause side effects as the disease progresses. We are hopeful that this technique for stimulating the immune system to recognize and then attack the cancer will result in longer-term remissions."
Paid maternity leave, pay equity and comparable pay for work of comparable worth -- those and other benefits that aid all working women and their families today -- are such an integral part of the U.S. workplace that we almost take them for granted. But they might not exist at all were it not for the efforts of Cornell's Alice Hanson Cook, one of the first researchers to study the problems faced by working women. Her pioneering work has influenced generations of scholars and activists -- from unionists to public policy analysts to experts in feminist jurisprudence -- and led them to transform working women's issues into societal priorities. This year marks the 100th anniversary of Cook's birth. A faculty member at Cornell's School of Industrial and Labor Relations from the early 1950s on, she died in 1998 after making her mark as one of the top researchers in her field. A conference to honor Cook's legacy will be held on Cornell's campus starting Friday evening, Nov. 21, and running all day Saturday, Nov. 22. The Saturday presentations are free and open to the public. Most of the events are in 105 Ives Hall. (November 18, 2003)